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ABSTRACT 
Acute leptin administration to rats inhibits insulin secretion either through centrally or 
peripherally mediated mechanisms. But type 2 diabetic obese individuals with 
impaired glucose utilization are also hyperleptinemic, which suggests that leptin 
action might depend on the duration of exposure to hyperleptinemia. This study 
examined the difference in blood glucose homeostasis following acute and chronic 
leptin administration in rats. Glucose tolerance curves were plotted for 14-week old 
male Sprague-Dawley rats treated with either normal saline (Control; n=8) or a single 
leptin injection (60ug/kg body weight - acute leptin; n=8) or subcutaneous leptin 
injections for 42 days (60 ug/kg body weight/day-chronic leptin; n=8). Following this, 
the rats were anaethetised with thiopentone sodium (100 mg/kg/body weight) and 
infused intravenously with 50 mg of glucose in water at a rate of 100 |il/min for 5 
minutes. Arterial blood samples were collected every 5 mins for the first 30 minutes 
for glucose estimation. Data were analysed using repeated measures MANOVA or 
one-way ANOVA with post-hoc analysis, and presented as mean ± SEM. Glucose 
clearance in acute leptin-treated rats did not differ from the controls. However, there 
was an overall significant decrease in plasma insulin levels with improved insulin 
sensitivity. This was achieved by increased insulin receptor expression whilst 
maintaining normal GLUT4 levels mainly through effective translocation from the 
GLUT4 vesicles. Compared to the acute leptin-treated rats, chronic leptin-treated 
animals had significantly higher blood glucose levels and hyperinsulinemia after 
glucose challenge. Chronic leptin administration decreased insulin sensitivity index 
by inhibiting the expression of insulin receptor. Conclusion it appears that the role of 
leptin in glucose clearance might be related to the duration of exposure to leptin. 
Acute leptin administration inhibited insulin secretion while maintaining normal 
glucose homeostasis by increasing insulin sensitivity by 1) increasing the expression 
of insulin receptor in the skeletal muscle, 2) by effectively maintaining GLUT4 
translocation from the storage vesicles probably mediated by PI3K pathway. Chronic 
administration of leptin for 42 days induced insulin resistance by decreasing the 
expression of insulin receptors in the insulin sensitive tissues. This resulted in the 
compensatory hyperinsulinemia. Since the chronic study was designed to mimic the 
chronic elevation of leptin or hyperleptinemic state in obese individuals, the findings 
from our study suggest that hyperleptinemia decreases expression of insulin receptors 
in insulin-sensitive tissues and thus promotes insulin resistance. 
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